ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

NCAB Committee Approves Recompletion Of Support Contracts

October 7, 1988

When Doctors Take Work Home: Houston Burglary Points to Security Breach

June 29, 2012

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005